Status:
UNKNOWN
The Role of Congenital Mucosal Immune System in the Airways of Patients With Chronic Obstructive Pulmonary Disease
Lead Sponsor:
Medical University of Lodz
Conditions:
COPD Exacerbation
Smoking, Tobacco
Eligibility:
All Genders
Brief Summary
The purpose of the study is to explore the role of congenital mucosal immune system in the airways of patients with COPD including the impact of ILCs (Innate lymphoid cells) on metabolism of epithelia...
Detailed Description
ILCs profiles, epithelium metabolism measured by VOCS and microbiome profiling (specific 16S rRNA-16S ribosomal RNA gene-targeted qPCR) will by determined in the airways of patients with COPD after th...
Eligibility Criteria
Inclusion
- Exclusion Criteria:
- Neoplasm
- Diabetes
- Astma
- acute airway infection in last 2 weeks
Exclusion
Key Trial Info
Start Date :
July 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04061122
Start Date
July 4 2018
End Date
June 30 2020
Last Update
August 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland
Lodz, Poland, 90-153